GUERRA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 11.700
AS - Asia 5.932
EU - Europa 4.963
SA - Sud America 867
Continente sconosciuto - Info sul continente non disponibili 557
AF - Africa 128
OC - Oceania 6
Totale 24.153
Nazione #
US - Stati Uniti d'America 11.021
SG - Singapore 1.819
IT - Italia 1.726
VN - Vietnam 1.423
CN - Cina 1.103
BR - Brasile 650
DE - Germania 644
HK - Hong Kong 609
RU - Federazione Russa 593
CA - Canada 558
SE - Svezia 469
IE - Irlanda 349
BD - Bangladesh 275
GB - Regno Unito 260
UA - Ucraina 204
FR - Francia 194
IN - India 172
FI - Finlandia 90
AT - Austria 84
AR - Argentina 69
ES - Italia 64
IQ - Iraq 62
TR - Turchia 61
DK - Danimarca 59
JP - Giappone 56
MX - Messico 52
KR - Corea 51
ID - Indonesia 48
NL - Olanda 47
PK - Pakistan 46
PL - Polonia 45
EC - Ecuador 40
VE - Venezuela 34
ZA - Sudafrica 34
SA - Arabia Saudita 32
BE - Belgio 28
PH - Filippine 28
CO - Colombia 27
KE - Kenya 21
CZ - Repubblica Ceca 19
CH - Svizzera 18
UZ - Uzbekistan 18
BG - Bulgaria 17
JO - Giordania 17
CL - Cile 15
MY - Malesia 15
JM - Giamaica 13
MA - Marocco 13
AE - Emirati Arabi Uniti 11
RO - Romania 11
TN - Tunisia 11
DZ - Algeria 10
EG - Egitto 10
PY - Paraguay 10
TH - Thailandia 10
UY - Uruguay 10
HN - Honduras 9
OM - Oman 9
IR - Iran 8
NI - Nicaragua 8
PT - Portogallo 8
AZ - Azerbaigian 7
CR - Costa Rica 7
IL - Israele 7
PE - Perù 7
AU - Australia 6
DO - Repubblica Dominicana 6
KG - Kirghizistan 6
LT - Lituania 6
PR - Porto Rico 6
AL - Albania 5
BO - Bolivia 5
EU - Europa 5
NP - Nepal 5
PS - Palestinian Territory 5
AO - Angola 4
GR - Grecia 4
KZ - Kazakistan 4
NG - Nigeria 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
LK - Sri Lanka 3
MK - Macedonia 3
MM - Myanmar 3
PA - Panama 3
SC - Seychelles 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 23.578
Città #
Ann Arbor 1.819
Singapore 1.150
Ashburn 1.115
San Jose 702
Hong Kong 589
Fairfield 557
Milan 541
Woodbridge 461
Ho Chi Minh City 448
Chandler 444
Houston 415
Wilmington 401
Toronto 372
Dublin 336
Frankfurt am Main 332
Hanoi 322
New York 292
Dearborn 248
Seattle 245
Santa Clara 227
Los Angeles 211
Jacksonville 200
Cambridge 178
Council Bluffs 177
Beijing 174
The Dalles 160
Dallas 156
Chicago 155
Princeton 137
Lissone 105
Shanghai 104
Rome 93
Hefei 89
Boardman 84
Nanjing 77
Lauterbourg 75
São Paulo 67
Vienna 65
Lawrence 62
Buffalo 60
Da Nang 59
Altamura 52
London 50
Moscow 50
Munich 49
Guangzhou 48
Columbus 47
San Diego 46
Seoul 45
Tokyo 45
Falls Church 43
Helsinki 40
Fremont 39
Montreal 39
Haiphong 38
Orem 38
Phoenix 37
Brooklyn 32
Warsaw 31
Lachine 30
Atlanta 29
Shenyang 29
Jinan 28
Naples 28
Biên Hòa 27
Hải Dương 27
Jakarta 27
Nanchang 27
Poplar 27
Chennai 26
Dong Ket 26
Nuremberg 26
Brussels 23
Bắc Ninh 23
Figino 23
Florence 23
Thái Nguyên 23
Boston 22
Monza 22
Newark 22
Washington 22
Ha Long 21
Ottawa 21
Vancouver 21
Denver 20
Manchester 20
Baghdad 19
Dhaka 19
Johannesburg 19
Ninh Bình 19
Stockholm 19
Vũng Tàu 19
Andover 18
Salt Lake City 18
Tashkent 18
Genoa 17
Hebei 17
Nairobi 17
Bari 16
Lahore 16
Totale 15.187
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 749
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 557
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 534
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 502
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 478
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 477
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 470
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 449
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 431
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 429
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 413
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 398
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 393
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 388
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 386
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 379
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 374
Respiratory motion management in PET/CT: applications and clinical usefulness 372
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 371
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 370
Motion management in PET/CT: Technological solutions 367
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 358
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 348
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 341
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 336
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 335
Erratum: ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 335
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 331
Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer 331
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 331
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 326
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 325
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 324
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 316
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 316
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 311
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 307
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? 299
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 296
Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 296
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 294
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 283
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 279
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 275
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 273
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation 270
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 270
A case of Melas (A3243G) on chronic dichloroacetate treatment 267
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 259
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 256
Imaging of lung inflammation during severe influenza A: H1N1 255
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 253
Focal bone lesions in hiv-positive patient treated with tenofovir 252
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 249
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 248
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 247
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 244
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial 243
Tidal changes on CT and progression of ARDS 242
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial 238
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 215
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 205
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 197
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial 194
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 194
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease 189
Respiratory Gating and the performance of PET/CT in pulmonary lesions 188
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 185
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases 180
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial 175
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma) 167
Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma? 150
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 150
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 147
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials 133
Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies 132
Immunoscintigraphy of ovarian cancer recurrences: comparison with surgical findings and CT scan or US results 131
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review 125
Current status of FDG-PET/CT in staging of adult lymphoma 125
Pitfalls and artifacts in [18F]-FDG PET imaging in children with lymphoma 120
Diagnostic Reference Levels in nuclear medicine for Positron Emission Tomography examinations: First Italian multicenter data collection 109
Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: PSA persistence, biochemical recurrence, hormone-sensitive and castration-resistant metastatic settings 60
A hypermetabolic pulmonary lesion in a patient with breast cancer 36
Totale 24.153
Categoria #
all - tutte 73.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022809 0 0 0 109 69 81 68 57 54 117 98 156
2022/20231.791 180 513 168 199 100 276 9 112 121 52 42 19
2023/20241.211 38 40 58 59 140 309 253 56 77 20 13 148
2024/20252.834 145 338 207 119 196 150 195 111 235 462 248 428
2025/20269.245 1.480 548 617 880 952 407 1.264 374 634 661 731 697
2026/20271.607 310 443 757 97 0 0 0 0 0 0 0 0
Totale 24.153